ClearBridge Investments’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $141M | Sell |
|
|||||
|
2024
Q3 | $127M | Buy |
|
|||||
|
2024
Q2 | $118M | Sell |
|
|||||
|
2024
Q1 | $121M | Buy |
|
|||||
|
2023
Q4 | $111M | Buy |
|
|||||
|
2023
Q3 | $73.1M | Sell |
|
|||||
|
2023
Q2 | $89.5M | Buy |
|
|||||
|
2023
Q1 | $56.9M | Buy |
|
|||||
|
2022
Q4 | $34.9M | Buy |
|
|||||
|
2022
Q3 | $30.3M | Buy |
|
|||||
|
2022
Q2 | $11.7M | Sell |
|
|||||
|
2022
Q1 | $14.7M | Sell |
|
|||||
|
2021
Q4 | $17.3M | Sell |
|
|||||
|
2021
Q3 | $16.2M | Sell |
|
|||||
|
2021
Q2 | $19.3M | Sell |
|
|||||
|
2021
Q1 | $16.1M | Sell |
|
|||||
|
2020
Q4 | $19.8M | Sell |
|
|||||
|
2020
Q3 | $16.6M | Buy |
|
|||||
|
2020
Q2 | $16.1M | Buy |
|
|||||
|
2020
Q1 | $7.86M | Buy |
|
|||||
|
2019
Q4 | $10.5M | Sell |
|
|||||
|
2019
Q3 | $5.87M | Buy |
|